PARK:NASDAQPark Dental Partners, Inc. Analysis
Data as of 2026-04-23 - not real-time
$17.83
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Park Dental Partners trades at $17.83, sitting just above its 20‑day SMA of 17.48 but marginally below the 50‑day SMA of 17.89, indicating a short‑term price edge while the longer‑term 200‑day SMA of 16.62 remains supportive. The RSI of 52 suggests neutral momentum, yet the MACD histogram is positive and the signal line is bullish, hinting at modest upside momentum. Price currently respects a technical support near $15.59 and faces resistance around $18.98, providing a clear trading range.
Fundamentally, the company delivers a 7.5% revenue growth rate but still posts a negative operating margin and a marginal profit margin, while generating positive operating cash flow of $17.6M and free cash flow of $11.7M. The forward PE of 13.5 is well below the industry average of 25.8, and the DCF‑derived fair value of $40.48 implies substantial long‑term upside despite the current market cap of only $80M. No dividend is paid, reflecting the firm’s focus on reinvestment and debt reduction.
Risk considerations include a high 30‑day volatility of over 50% and a beta of 0.82, indicating moderate market sensitivity, while decreasing volume and a small market cap raise liquidity concerns. The healthcare‑facility sector carries medium regulatory exposure, but the company’s geographic footprint is limited to three U.S. states, keeping currency and geographic risk low.
Fundamentally, the company delivers a 7.5% revenue growth rate but still posts a negative operating margin and a marginal profit margin, while generating positive operating cash flow of $17.6M and free cash flow of $11.7M. The forward PE of 13.5 is well below the industry average of 25.8, and the DCF‑derived fair value of $40.48 implies substantial long‑term upside despite the current market cap of only $80M. No dividend is paid, reflecting the firm’s focus on reinvestment and debt reduction.
Risk considerations include a high 30‑day volatility of over 50% and a beta of 0.82, indicating moderate market sensitivity, while decreasing volume and a small market cap raise liquidity concerns. The healthcare‑facility sector carries medium regulatory exposure, but the company’s geographic footprint is limited to three U.S. states, keeping currency and geographic risk low.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD crossover signals near‑term momentum
- Current price below DCF fair value, offering upside
- Support level at $15.59 provides downside cushion
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Revenue growth of 7.5% but ongoing operating losses
- Positive operating and free cash flow supports stability
- Valuation still attractive relative to peers
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value of $40.48 suggests significant long‑term upside
- Low forward PE versus industry indicates deep discount
- Strong cash generation can fund turnaround and debt reduction
Key Metrics & Analysis
Financial Health
Revenue Growth7.50%
Profit Margin-0.15%
P/E Ratio13.5
ROE-4.09%
ROA0.15%
Debt/Equity276.80
P/B Ratio3.5
Op. Cash Flow$17.6M
Free Cash Flow$11.7M
Industry P/E25.8
Technical Analysis
TrendNeutral
RSI52.4
Support$15.59
Resistance$18.98
MA 20$17.48
MA 50$17.89
MA 200$16.62
MACDBullish
VolumeDecreasing
Fear & Greed Index86.34
Valuation
Fair Value$40.48
Target Price$22.75
Upside/Downside27.63%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.82
Volatility50.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.